首页 > 最新文献

American journal of cardiovascular disease最新文献

英文 中文
Artificial intelligence for Brugada syndrome diagnosis and gene variants interpretation. 用于 Brugada 综合征诊断和基因变异解释的人工智能。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/YQHQ1079
Mobina Sahebnasagh, Mohammad Hadi Farjoo

Brugada Syndrome (BrS) is a hereditary cardiac condition associated with an elevated risk of lethal arrhythmias, making precise and prompt diagnosis vital to prevent life-threatening outcomes. The diagnosis of BrS is challenging due to the requirement of invasive drug challenge tests, limited human visual capacity to detect subtle electrocardiogram (ECG) patterns, and the transient nature of the disease. Artificial intelligence (AI) can detect almost all patterns of BrS in ECG, some of which are even beyond the capability of expert eyes. AI is subcategorized into several models, with deep learning being considered the most beneficial, boasting its highest accuracy among the other models. With the capability to discriminate subtle data and analyze extensive datasets, AI has achieved higher accuracy, sensitivity, and specificity compared to trained cardiologists. Meanwhile, AI proficiency in managing complex data enables us to discover unclassified genetic variants. AI can also analyze data extracted from induced pluripotent stem cell-derived cardiomyocytes to distinguish BrS from other inherited cardiac arrhythmias. The aim of this study is to present a synopsis of the evolution of various algorithms of artificial intelligence utilized in the diagnosis of BrS and compare their diagnostic abilities to trained cardiologists. In addition, the application of AI for classification of BrS gene variants is also briefly discussed.

{"title":"Artificial intelligence for Brugada syndrome diagnosis and gene variants interpretation.","authors":"Mobina Sahebnasagh, Mohammad Hadi Farjoo","doi":"10.62347/YQHQ1079","DOIUrl":"10.62347/YQHQ1079","url":null,"abstract":"<p><p>Brugada Syndrome (BrS) is a hereditary cardiac condition associated with an elevated risk of lethal arrhythmias, making precise and prompt diagnosis vital to prevent life-threatening outcomes. The diagnosis of BrS is challenging due to the requirement of invasive drug challenge tests, limited human visual capacity to detect subtle electrocardiogram (ECG) patterns, and the transient nature of the disease. Artificial intelligence (AI) can detect almost all patterns of BrS in ECG, some of which are even beyond the capability of expert eyes. AI is subcategorized into several models, with deep learning being considered the most beneficial, boasting its highest accuracy among the other models. With the capability to discriminate subtle data and analyze extensive datasets, AI has achieved higher accuracy, sensitivity, and specificity compared to trained cardiologists. Meanwhile, AI proficiency in managing complex data enables us to discover unclassified genetic variants. AI can also analyze data extracted from induced pluripotent stem cell-derived cardiomyocytes to distinguish BrS from other inherited cardiac arrhythmias. The aim of this study is to present a synopsis of the evolution of various algorithms of artificial intelligence utilized in the diagnosis of BrS and compare their diagnostic abilities to trained cardiologists. In addition, the application of AI for classification of BrS gene variants is also briefly discussed.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"1-12"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic intervention with trimetazidine improves intracardiac hemodynamics and reduces re-hospitalizations in patients with advanced heart failure. 曲美他嗪代谢干预可改善心内血流动力学,减少晚期心力衰竭患者的再次住院。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/ASXF2065
Hamayak S Sisakian, Nina A Muradyan, Anna V Babayan, Lilit A Sargsyan, Sama A Shamyar, Armine S Chopikyan, Syuzanna A Shahnazaryan

Objectives: We tested whether management with metabolic cytoprotective and antiischemic agent trimetazidine may reduce readmissions in advanced heart failure (HF) patients through the possible improvement of left ventricular ejection fraction (LV EF) and filling pressure.

Methods: This was a single-center prospective open-label study. The study population included initially 40 patients with advanced HF and EF <30%, NYHA III-IV functional class, significant restriction of physical activity and at least 1 hospitalization during the last 12 months. After discharge patients were assigned to additional treatment with trimetazidine 80 mg/daily dose (20 patients) or standard guideline-based pharmacological therapy (20 patients). After enrollment patients underwent a total of four outpatient clinical and echocardiographic examinations (baseline before discharge, 2 weeks, 1, 3 and 6 months after the discharge). The echocardiographic assessment of EF and LV filling pressure by Tissue Doppler were performed blindly.

Results: At 6 months, trimetazidine-treated patients had an improvement of LV EF (from 23.7% to 25%) as compared to controls (from 22.5% to 22.6%). Tissue Doppler study showed a decrease of LV filling pressure in trimetazidine treated group from 15.1 at baseline to 13.7 after 6 months of treatment. In the control group, LV filling pressure remained unchanged (from 16.78 to 16.7) (P<0.001). The rate of hospitalizations for cardiovascular causes was reduced at 6 months (83.3% vs 70.0%).

Conclusions: Treatment with trimetazidine 80 mg/daily in addition to standard guideline-based therapy for 6-months decreased hospitalization, improved systolic function and LV filling pressure in advanced HF patients.

{"title":"Metabolic intervention with trimetazidine improves intracardiac hemodynamics and reduces re-hospitalizations in patients with advanced heart failure.","authors":"Hamayak S Sisakian, Nina A Muradyan, Anna V Babayan, Lilit A Sargsyan, Sama A Shamyar, Armine S Chopikyan, Syuzanna A Shahnazaryan","doi":"10.62347/ASXF2065","DOIUrl":"10.62347/ASXF2065","url":null,"abstract":"<p><strong>Objectives: </strong>We tested whether management with metabolic cytoprotective and antiischemic agent trimetazidine may reduce readmissions in advanced heart failure (HF) patients through the possible improvement of left ventricular ejection fraction (LV EF) and filling pressure.</p><p><strong>Methods: </strong>This was a single-center prospective open-label study. The study population included initially 40 patients with advanced HF and EF <30%, NYHA III-IV functional class, significant restriction of physical activity and at least 1 hospitalization during the last 12 months. After discharge patients were assigned to additional treatment with trimetazidine 80 mg/daily dose (20 patients) or standard guideline-based pharmacological therapy (20 patients). After enrollment patients underwent a total of four outpatient clinical and echocardiographic examinations (baseline before discharge, 2 weeks, 1, 3 and 6 months after the discharge). The echocardiographic assessment of EF and LV filling pressure by Tissue Doppler were performed blindly.</p><p><strong>Results: </strong>At 6 months, trimetazidine-treated patients had an improvement of LV EF (from 23.7% to 25%) as compared to controls (from 22.5% to 22.6%). Tissue Doppler study showed a decrease of LV filling pressure in trimetazidine treated group from 15.1 at baseline to 13.7 after 6 months of treatment. In the control group, LV filling pressure remained unchanged (from 16.78 to 16.7) (P<0.001). The rate of hospitalizations for cardiovascular causes was reduced at 6 months (83.3% vs 70.0%).</p><p><strong>Conclusions: </strong>Treatment with trimetazidine 80 mg/daily in addition to standard guideline-based therapy for 6-months decreased hospitalization, improved systolic function and LV filling pressure in advanced HF patients.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"13-20"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternating between exit sites of retrograde slow pathway during fast-slow atrioventricular nodal reentrant tachycardia: case report. 快慢型房室结复律性心动过速时逆行慢速通路出口部位的交替:病例报告。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/XMJR4018
Mihoko Kawabata, Yasuhiro Shirai, Tatsuaki Kamata, Tomoyuki Kawashima, Ryo Yonai, Kaoru Okishige, Kenzo Hirao

We report a case of a 57-year-old male with narrow QRS tachycardia exhibiting the alternance of the cycle length. Differential diagnoses include orthodromic atrioventricular reciprocating tachycardia with alternating antegrade atrioventricular (AV) nodal pathways, atrioventricular nodal re-entrant tachycardia (AVNRT) with alternating AV nodal pathways, and atrial tachycardia with alternating antegrade AV nodal pathways or with Wenckebach periodicity. In electrophysiological study the tachycardia showed alternance in the retrograde atrial conduction sequence and the cycle length. The alternation was caused by that of the HA intervals, between the shorter HA interval with the earliest atrial activation recorded in coronary sinus (CS), and the longer HA interval with that in His bundle region. The tachycardia was diagnosed with fast-slow form of AVNRT exhibiting the alternance of the earliest atrial activation sites. Electroanatomical 3D mapping further revealed that the exit site of retrograde slow pathway (SP) alternated between the left inferior extension (LIE) inside the CS, and the right inferior extension (RIE) in the posterior tricuspid annulus although among conventional electrode catheters the earliest site was the His bundle region. After ablation of the exit site of LIE, the alternation disappeared and fast-slow AVNRT showing a uniform retrograde atrial activation for which the earliest atrial activation site was the exit of RIE sustained. A single application of ablation at this point was insufficient, thereafter conventional SP ablation was added. Then, the ventriculoatrial conduction disappeared and no tachycardia was inducible even with isoproterenol administration. This case is followed by a review of the literature.

{"title":"Alternating between exit sites of retrograde slow pathway during fast-slow atrioventricular nodal reentrant tachycardia: case report.","authors":"Mihoko Kawabata, Yasuhiro Shirai, Tatsuaki Kamata, Tomoyuki Kawashima, Ryo Yonai, Kaoru Okishige, Kenzo Hirao","doi":"10.62347/XMJR4018","DOIUrl":"10.62347/XMJR4018","url":null,"abstract":"<p><p>We report a case of a 57-year-old male with narrow QRS tachycardia exhibiting the alternance of the cycle length. Differential diagnoses include orthodromic atrioventricular reciprocating tachycardia with alternating antegrade atrioventricular (AV) nodal pathways, atrioventricular nodal re-entrant tachycardia (AVNRT) with alternating AV nodal pathways, and atrial tachycardia with alternating antegrade AV nodal pathways or with Wenckebach periodicity. In electrophysiological study the tachycardia showed alternance in the retrograde atrial conduction sequence and the cycle length. The alternation was caused by that of the HA intervals, between the shorter HA interval with the earliest atrial activation recorded in coronary sinus (CS), and the longer HA interval with that in His bundle region. The tachycardia was diagnosed with fast-slow form of AVNRT exhibiting the alternance of the earliest atrial activation sites. Electroanatomical 3D mapping further revealed that the exit site of retrograde slow pathway (SP) alternated between the left inferior extension (LIE) inside the CS, and the right inferior extension (RIE) in the posterior tricuspid annulus although among conventional electrode catheters the earliest site was the His bundle region. After ablation of the exit site of LIE, the alternation disappeared and fast-slow AVNRT showing a uniform retrograde atrial activation for which the earliest atrial activation site was the exit of RIE sustained. A single application of ablation at this point was insufficient, thereafter conventional SP ablation was added. Then, the ventriculoatrial conduction disappeared and no tachycardia was inducible even with isoproterenol administration. This case is followed by a review of the literature.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"39-47"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender specific echocardiographic prevalence of valvular stenosis and regurgitations in a large inpatient database of 24,265 patients. 由 24,265 名患者组成的大型住院患者数据库中瓣膜狭窄和反流的性别特异性超声心动图患病率。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/HYOC9461
Mohammad Reza Movahed, Ashkan Bahrami, Reza Eshraghi

Introduction: Prevalence of different valvular pathologies has not been reported in female and male patients in large population-based studies. The goal of this study was to report the gender-specific prevalence of various valvular pathologies.

Methods: We retrospectively analyzed 24,265 echocardiograms performed between 1984 and 1998. The prevalence of mitral regurgitation (MR) aortic valve regurgitation (AR) and stenosis (AS), and tricuspid regurgitation (TR) were calculated in female and male patients.

Results: Echocardiograms were performed on 12,926 (53%) female and 11,339 (47%) male patients. Gender-specific echocardiographic prevalence of different valvular abnormalities was as follows: Prevalence of mitral regurgitations was similar in women and men (25% vs 24.7%). Aortic regurgitation was higher in males (5.5 vs 14.9%, P < 0.001). Aortic stenosis prevalence was similar between both genders (2.1 vs 2.3%). Tricuspid valve regurgitations were slightly higher in females (18.5 vs 16.7%, P < 0.001).

Conclusion: In this study, we found a significantly higher prevalence of tricuspid valve regurgitation in women. Aortic regurgitation was more prevalent in men. Aortic stenosis and mitral regurgitation had similar prevalence in both genders.

{"title":"Gender specific echocardiographic prevalence of valvular stenosis and regurgitations in a large inpatient database of 24,265 patients.","authors":"Mohammad Reza Movahed, Ashkan Bahrami, Reza Eshraghi","doi":"10.62347/HYOC9461","DOIUrl":"10.62347/HYOC9461","url":null,"abstract":"<p><strong>Introduction: </strong>Prevalence of different valvular pathologies has not been reported in female and male patients in large population-based studies. The goal of this study was to report the gender-specific prevalence of various valvular pathologies.</p><p><strong>Methods: </strong>We retrospectively analyzed 24,265 echocardiograms performed between 1984 and 1998. The prevalence of mitral regurgitation (MR) aortic valve regurgitation (AR) and stenosis (AS), and tricuspid regurgitation (TR) were calculated in female and male patients.</p><p><strong>Results: </strong>Echocardiograms were performed on 12,926 (53%) female and 11,339 (47%) male patients. Gender-specific echocardiographic prevalence of different valvular abnormalities was as follows: Prevalence of mitral regurgitations was similar in women and men (25% vs 24.7%). Aortic regurgitation was higher in males (5.5 vs 14.9%, P < 0.001). Aortic stenosis prevalence was similar between both genders (2.1 vs 2.3%). Tricuspid valve regurgitations were slightly higher in females (18.5 vs 16.7%, P < 0.001).</p><p><strong>Conclusion: </strong>In this study, we found a significantly higher prevalence of tricuspid valve regurgitation in women. Aortic regurgitation was more prevalent in men. Aortic stenosis and mitral regurgitation had similar prevalence in both genders.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"21-28"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography.
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/QIEZ3054
Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş

Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.

{"title":"Overcoming therapeutic challenges in a case of refractory chylothorax following blunt abdominal trauma through the utility of cone-beam computed tomography lymphangiography.","authors":"Hasan Dinc, Sükrü Oguz, Selcuk Akkaya, Elif Merve Bal, Atilla Türkyılmaz, Bekir Sami Karapolat, Celal Tekinbaş","doi":"10.62347/QIEZ3054","DOIUrl":"10.62347/QIEZ3054","url":null,"abstract":"<p><p>Chylothorax development following blunt abdominal trauma is a rare event. While low volume chylothoraxes usually improve with conservative treatment, invasive interventions are required in high-volume chylothoraxes with daily drainage exceeding 1000 ml. We report a case of a 14-year-old boy who developed high-volume (>3 L/d) chylothorax on the left side following blunt abdominal trauma. The patient did not respond to conservative treatments. He underwent thoracic duct ligation three times, with percutaneous lymphatic interventions, and percutaneous Lipiodol-glue mixture injections under computed tomography (CT) guidance, but all treatments were unsuccessful. We describe the four-month multidisciplinary challenge in this case that was ultimately successfully treated by surgical ligation of aberrant and/or collateral lymphatics draining from the left abdomen to the left pleural cavity, with the help of the novel cone-beam computed tomography (CBCT) lymphangiography (LAG) technique.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"48-55"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024. 2024 年在埃塞俄比亚亚的斯亚贝巴 Gesund 心脏和医疗中心接受经皮冠状动脉介入治疗的患者的临床特征和疗效。
IF 1.3 Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI: 10.62347/RIAQ1956
Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse

Introduction: Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.

Objective: To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.

Methods: This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.

Results: The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.

Conclusion and recommendations: Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.

{"title":"Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024.","authors":"Kesete Eskias, Alemayehu Bekele, Ousman Adal, Heyria Hussien, Lemlem Beza Demisse","doi":"10.62347/RIAQ1956","DOIUrl":"10.62347/RIAQ1956","url":null,"abstract":"<p><strong>Introduction: </strong>Percutaneous coronary intervention (PCI) is a critical procedure for improving blood flow by alleviating arterial blockage. However, its availability in Ethiopia is limited because of insufficient resources, staff, and infrastructure.</p><p><strong>Objective: </strong>To evaluate the clinical characteristics and outcomes of patients who underwent percutaneous coronary intervention at Gesund Cardiac and Medical Center in Addis Ababa, Ethiopia, in 2024.</p><p><strong>Methods: </strong>This retrospective observational chart review included 224 patients who underwent percutaneous coronary intervention. Data were collected using a standardized checklist, imported into EPI information v7, and analyzed using SPSS v26. A binary logistic regression model was used to identify factors associated with percutaneous coronary intervention.</p><p><strong>Results: </strong>The study found that most participants (n = 186, 83%) were male, with a mean age of 57.82 ± 11.5 years. Diabetes mellitus was prevalent among participants (n = 135, 60.3%), followed by hypertension (n = 127, 56.7%). A notable portion (n = 31, 13.8%) had previously undergone percutaneous coronary intervention. Most patients presented with typical chest pain, with ST-Elevation Myocardial Infarction (STEMI) being the primary indication for percutaneous coronary intervention. Post-procedure complications includes significant bleeding (n = 6, 2.6%), myocardial infarction (n = 20, 8.9%), death (n = 2, 0.9%), transfer to another hospital (n = 12, 5.4%), and acute kidney injury (n = 16, 7.14%). The use of bare metal stents was significantly associated with transfer to other hospitals (AOR = 5; 95% CI = 1.69-10.29). Male gender (AOR = 0.09; 95% CI = 0.03-0.34) and a history of myocardial infarction (AOR = 10; 95% CI = 2.31-13.31) were linked to an increased risk of post-percutaneous coronary intervention death.</p><p><strong>Conclusion and recommendations: </strong>Our findings suggest that coronary artery stenosis (CAS) is more prevalent in older individuals and men. Chronic illnesses often coexist with coronary artery stenosis, thereby complicating the prognosis. Interestingly, men exhibited a lower risk of unfavorable outcomes compared to women. Adherence to procedural guidelines and effective management techniques are essential for improving patient outcomes following percutaneous coronary intervention.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"15 1","pages":"29-38"},"PeriodicalIF":1.3,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial. 阈值负荷的吸气肌训练和呼吸生物反馈对冠脉搭桥后保持吸气肌力量和肺活量的影响:一项随机临床试验。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/JBMU4830
Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared

Objectives: Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.

Methods: A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).

Results: Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.

Conclusion: TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.

目的:术后肺部并发症(POPC)是冠状动脉旁路移植术(CABG)等心脏手术后常见的并发症,受麻醉和手术创伤等因素的影响。吸气肌训练(IMT)与视觉生物反馈可以减轻这些并发症。本研究探讨阈值负荷吸气肌训练(TL-IMT)结合呼吸生物反馈对冠脉搭桥患者住院期吸气肌动态强度(s指数)的影响。方法:对德黑兰Shahid Modares医院的38例CABG候选者进行单盲研究。参与者被随机分为两组:生物反馈的TL-IMT组和安慰剂IMT组。使用Power Breath K5装置以最大动态吸气强度的30%进行TL-IMT练习,并在屏幕上显示视觉生物反馈。安慰剂组在没有生物反馈的情况下以最小负荷进行相同的锻炼。两组均接受标准的呼吸物理治疗。术前(T1)、术后1天(T2)和出院时(T3)分别测定s指数、吸气峰值流量(PIF)和肺活量(VC)。结果:两组均有明显变化,T1 - T2降低,T2 - T3升高。在研究组中,T3值与T1时相同,而安慰剂IMT组T3值明显下降。术后两组患者s指数均有下降。与对照组相比,研究组T3-T2和T3-T1的变化更为明显,但T2-T1之间无明显差异。出院时,TL-IMT组s指数高于安慰剂组,恢复到术前水平。此外,TL-IMT组在PIF和VC方面也有改善。结论:视觉生物反馈TL-IMT能有效维持心脏手术患者动态吸气肌力量,改善肺关键参数。这些结果表明,将TL-IMT与生物反馈相结合可以提高术后恢复,减少POPC的发生率。
{"title":"The impact of threshold-loaded inspiratory muscle training and respiratory biofeedback on preserving inspiratory muscle strength and vital capacity after CABG: a randomized clinical trial.","authors":"Bahareh Mehregan-Far, Sedigheh Sadat Naimi, Mohsen Abedi, Parsa Salemi, Seyed Ahmad Raeis-Sadat, Mahmood Beheshti-Monfared","doi":"10.62347/JBMU4830","DOIUrl":"10.62347/JBMU4830","url":null,"abstract":"<p><strong>Objectives: </strong>Postoperative pulmonary complications (POPC) are common after cardiac surgeries such as coronary artery bypass grafting (CABG) and are influenced by factors including anesthesia and surgical trauma. Inspiratory muscle training (IMT) with visual biofeedback may mitigate these complications. This study investigates the impact of threshold loading inspiratory muscle training (TL-IMT) combined with respiratory biofeedback on the dynamic strength of inspiratory muscles (S-index) in patients undergoing CABG surgery during their hospitalization phase.</p><p><strong>Methods: </strong>A single-blind study was conducted with 38 CABG candidates at Shahid Modares Hospital, Tehran. Participants were randomized into two groups: the TL-IMT with biofeedback group and the placebo IMT group. TL-IMT exercises were performed at 30% of maximum dynamic inspiratory strength using the Power Breath K5 device, with visual biofeedback displayed on the screen. The placebo group performed the same exercises at minimal load without biofeedback. Both groups received standard respiratory physiotherapy. Measurements of S-index, peak inspiratory flow (PIF), and vital capacity (VC) were taken before surgery (T1), one day after surgery (T2), and at discharge (T3).</p><p><strong>Results: </strong>Both groups showed significant changes, with a decrease from T1 to T2 and an increase from T2 to T3. In the study group, T3 values remained the same as at T1, while the placebo IMT group experienced a significant decrease. After surgery, both groups had a drop in the S-index. However, the study group saw more pronounced changes between T3-T2 and T3-T1 compared to the control group, although no significant difference was found between T2-T1. By the time of discharge, the TL-IMT group had higher S-index values than the placebo group, returning to preoperative levels. Additionally, the TL-IMT group showed improvements in PIF and VC.</p><p><strong>Conclusion: </strong>TL-IMT with visual biofeedback effectively maintains dynamic inspiratory muscle strength and improves key pulmonary parameters in cardiac surgery patients. These findings suggest that integrating TL-IMT with biofeedback can enhance postoperative recovery and reduce the incidence of POPC.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"375-383"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sertraline in depressed patients with or at risk for coronary heart disese: a systemic review. 舍曲林在伴有或有冠心病风险的抑郁症患者中的应用:一项系统综述。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/AXZC9187
Kiana Seifouri, Reza Kahdemi, Fatemeh Ahmadi Hajikolaei, Fatemeh Rasekh, Fariba Azadikhah, Ida Mehraban, Reyhaneh Alikhani, Alireza Mirjalili, Milad Alipour, Sayedeh-Fatemeh Sadat-Madani, Fatemeh Chichagi, Saeed Zivari Lashkajani, Amir Abdi, Mohaddeseh Belbasi, Ata Akhtari Kohnehshahri, Niloofar Deravi, Mahdyieh Naziri, Yasamin Pishkari, Melika Arab Bafrani, Vahid Aghsaghloo, Ali Faghih Habibi

Background and aims: Depression is a prevalent comorbidity among patients with coronary heart disease (CHD). While recent studies have hinted at a possible association between CHD and antidepressant medications like sertraline, the existing evidence remains inconclusive. To investigate this potential link, we conducted a comprehensive systematic review.

Methods: We systematically searched PubMed, Google Scholar, and Scopus for relevant articles published up to March 2023. After a thorough screening of titles and abstracts, 12 studies were included in our review.

Results: The included studies, spanning from 1999 to 2021, comprised 11 randomized controlled trials (RCTs) and one pilot study. A total of 2767 participants with major depressive disorder and a history of cardiovascular disease or at risk for such events were included. The majority of these studies demonstrated improvements in mood status among patients treated with serotonin-targeting antidepressants and a reduced risk of cardiovascular events, as measured by various outcomes. While some cardiac adverse effects were observed with serotonin treatment, these did not reach statistical significance.

Conclusion: Our findings provide evidence supporting the beneficial effects of serotonin-targeting antidepressants for both depressive symptoms and the prevention of coronary adverse outcomes. These results highlight the potential value of serotonin-based treatments for depression in high-risk populations.

背景与目的:抑郁症是冠心病(CHD)患者的常见合并症。虽然最近的研究暗示了冠心病与舍曲林等抗抑郁药物之间的可能联系,但现有的证据仍然没有定论。为了调查这种潜在的联系,我们进行了一项全面的系统综述。方法:系统检索PubMed、谷歌Scholar和Scopus,检索截止到2023年3月发表的相关文章。在对题目和摘要进行全面筛选后,我们的综述纳入了12项研究。结果:纳入的研究时间跨度为1999年至2021年,包括11项随机对照试验(rct)和1项试点研究。共有2767名患有重度抑郁症、有心血管疾病史或有此类事件风险的参与者被纳入研究。这些研究中的大多数表明,在接受以血清素为目标的抗抑郁药治疗的患者中,情绪状态有所改善,心血管事件的风险降低,这是通过各种结果来衡量的。虽然观察到一些心脏不良反应与血清素治疗,这些没有达到统计学意义。结论:我们的研究结果为血清素靶向抗抑郁药对抑郁症状和预防冠状动脉不良后果的有益作用提供了证据。这些结果突出了以血清素为基础的治疗高危人群抑郁症的潜在价值。
{"title":"Sertraline in depressed patients with or at risk for coronary heart disese: a systemic review.","authors":"Kiana Seifouri, Reza Kahdemi, Fatemeh Ahmadi Hajikolaei, Fatemeh Rasekh, Fariba Azadikhah, Ida Mehraban, Reyhaneh Alikhani, Alireza Mirjalili, Milad Alipour, Sayedeh-Fatemeh Sadat-Madani, Fatemeh Chichagi, Saeed Zivari Lashkajani, Amir Abdi, Mohaddeseh Belbasi, Ata Akhtari Kohnehshahri, Niloofar Deravi, Mahdyieh Naziri, Yasamin Pishkari, Melika Arab Bafrani, Vahid Aghsaghloo, Ali Faghih Habibi","doi":"10.62347/AXZC9187","DOIUrl":"10.62347/AXZC9187","url":null,"abstract":"<p><strong>Background and aims: </strong>Depression is a prevalent comorbidity among patients with coronary heart disease (CHD). While recent studies have hinted at a possible association between CHD and antidepressant medications like sertraline, the existing evidence remains inconclusive. To investigate this potential link, we conducted a comprehensive systematic review.</p><p><strong>Methods: </strong>We systematically searched PubMed, Google Scholar, and Scopus for relevant articles published up to March 2023. After a thorough screening of titles and abstracts, 12 studies were included in our review.</p><p><strong>Results: </strong>The included studies, spanning from 1999 to 2021, comprised 11 randomized controlled trials (RCTs) and one pilot study. A total of 2767 participants with major depressive disorder and a history of cardiovascular disease or at risk for such events were included. The majority of these studies demonstrated improvements in mood status among patients treated with serotonin-targeting antidepressants and a reduced risk of cardiovascular events, as measured by various outcomes. While some cardiac adverse effects were observed with serotonin treatment, these did not reach statistical significance.</p><p><strong>Conclusion: </strong>Our findings provide evidence supporting the beneficial effects of serotonin-targeting antidepressants for both depressive symptoms and the prevention of coronary adverse outcomes. These results highlight the potential value of serotonin-based treatments for depression in high-risk populations.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"318-329"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Movahed protocol and algorithm for preventing intubation in patients with acute or sympathetic crashing acute pulmonary edema (SCAPE) without cardiogenic shock by repeated administration of buccal nitroglycerin ointments. 反复给予口腔硝酸甘油软膏防止急性或交感性急性肺水肿(SCAPE)无心源性休克患者插管的Movahed方案和算法。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/CXMD7229
Mohammad Reza Movahed

Patients presenting with severe acute cardiogenic pulmonary edema with hypoxia commonly require intubation until heart failure treatments take effect. A new term describing similar condition is called sympathetic crashing acute pulmonary edema (SCAPE). It is also called Flash pulmonary edema. Immediate pre- and afterload reduction can abort intubation. Using rapid repeated buccal administrations of nitroglycerin ointments can prevent intubation by rapidly reducing pre- and afterload as long as systolic blood pressure remains adequate without cardiogenic shock. A case series of 6 patients who needed intubation due to severe cardiogenic pulmonary edema and hypoxia despite 100% O2 administration without the presence of cardiogenic shock were successfully treated with repeated buccal administration of nitroglycerin ointments. Approximately half of an inch of nitroglycerin ointment (nitropaste) was buccally administrated every 60 seconds as long as repeated blood pressure measurements every minute before each repeated administration remained above 120 mmHg. Complete response with resolution of dyspnea with minimal oxygen requirement achieved in less than 30 minutes in all patients. Intubation was prevented in all 6 patients. No adverse events occurred in any of the patients. A treatment protocol and algorithm are developed based on these patients and reported cases in the literature for prevention of intubation in these patients. Rapid repeated buccal administration of nitroglycerin ointment is highly effective in preventing intubation and mechanical ventilation in patients with any acute pulmonary edema or SCAPE and hypoxia without cardiogenic shock.

出现严重急性心源性肺水肿并缺氧的患者通常需要插管,直到心力衰竭治疗生效。描述类似情况的一个新术语称为交感冲击急性肺水肿(SCAPE)。也叫闪发性肺水肿。立即的术前和术后负荷减少会导致插管失败。只要收缩压保持适当且无心源性休克,使用快速反复的口腔给药硝酸甘油软膏可以通过快速降低前负荷和后负荷来防止插管。本文报道了6例因严重心源性肺水肿和缺氧而需要插管的患者,尽管给予100%的氧气,但没有心源性休克,我们成功地通过反复口腔给药硝酸甘油软膏治疗。只要每次重复给药前每分钟重复一次血压测量保持在120 mmHg以上,每60秒口腔给药大约半英寸的硝酸甘油软膏(硝化膏)。所有患者均在30分钟内完全缓解呼吸困难,需氧量最低。6例患者均未插管。所有患者均未发生不良事件。根据这些患者和文献中报道的病例,制定了预防这些患者插管的治疗方案和算法。快速反复口腔给药硝酸甘油软膏对无心源性休克的急性肺水肿或急性肺水肿及缺氧患者预防插管和机械通气非常有效。
{"title":"The Movahed protocol and algorithm for preventing intubation in patients with acute or sympathetic crashing acute pulmonary edema (SCAPE) without cardiogenic shock by repeated administration of buccal nitroglycerin ointments.","authors":"Mohammad Reza Movahed","doi":"10.62347/CXMD7229","DOIUrl":"10.62347/CXMD7229","url":null,"abstract":"<p><p>Patients presenting with severe acute cardiogenic pulmonary edema with hypoxia commonly require intubation until heart failure treatments take effect. A new term describing similar condition is called sympathetic crashing acute pulmonary edema (SCAPE). It is also called Flash pulmonary edema. Immediate pre- and afterload reduction can abort intubation. Using rapid repeated buccal administrations of nitroglycerin ointments can prevent intubation by rapidly reducing pre- and afterload as long as systolic blood pressure remains adequate without cardiogenic shock. A case series of 6 patients who needed intubation due to severe cardiogenic pulmonary edema and hypoxia despite 100% O2 administration without the presence of cardiogenic shock were successfully treated with repeated buccal administration of nitroglycerin ointments. Approximately half of an inch of nitroglycerin ointment (nitropaste) was buccally administrated every 60 seconds as long as repeated blood pressure measurements every minute before each repeated administration remained above 120 mmHg. Complete response with resolution of dyspnea with minimal oxygen requirement achieved in less than 30 minutes in all patients. Intubation was prevented in all 6 patients. No adverse events occurred in any of the patients. A treatment protocol and algorithm are developed based on these patients and reported cases in the literature for prevention of intubation in these patients. Rapid repeated buccal administration of nitroglycerin ointment is highly effective in preventing intubation and mechanical ventilation in patients with any acute pulmonary edema or SCAPE and hypoxia without cardiogenic shock.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"368-374"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical cardiac rehabilitation effects on cardio-metabolic outcomes in the patients with hypertrophic cardiomyopathy: a systematic review. 心脏物理康复对肥厚性心肌病患者心脏代谢结局的影响:一项系统综述。
IF 1.3 Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI: 10.62347/JOYM3506
Fatemeh Chichagi, Kimiya Ghanbari-Mardasi, Niyousha Shirsalimi, Mahboobeh Sheikh, Diaa Hakim

Objectives: This systematic review aimed to review existing evidence to evaluate the effects of physical cardiac rehabilitation on cardio-pulmonary outcomes in the patients with hypertrophic cardiomyopathy (HCM).

Methods: We conducted a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. The initial search led to 1222 citations after removing duplicate results. We included only English-written studies published since 2013 (2013-2023). Ultimately, we retrieved five studies, involving 235 participants. We used the Cochrane Risk of Bias Tool for randomized trials (RoB2) and risk of bias in non-randomized studies of intervention (ROBINS-I) for evaluating the risk of bias in randomized and non-randomized studies, respectively.

Results: Results showed that four training programs improved participants' functional capacity by up to 46%. Improvements in weight, BMI, echocardiography, and remodeling parameters (left atrium volume index, premature ventricular contraction burden, pulmonary artery systolic pressure), exercise test results (minute ventilation/carbon dioxide production, peak workload, heart rate reserve, exercise duration, peak heart rate, peak systolic pressure, and blood pressure response to exercise normalization), and a decrease in N- Terminal Pro-Brain Natriuretic Peptide (NT-pro BNP) were reported in these studies. No major adverse events, including sustained tachyarrhythmia, implantable cardioverter-defibrillator discharge, and sudden cardiac death were reported.

Conclusion: Supervised exercise training is safe and helpful for patients diagnosed with HCM. It can improve exercise capacity and is considered an adjunctive therapeutic option.

目的:本系统综述旨在回顾现有证据,以评估心脏物理康复对肥厚性心肌病(HCM)患者心肺预后的影响。方法:系统检索PubMed、Web of Science、Embase、Scopus、谷歌Scholar等数据库。在删除重复结果后,最初的搜索导致1222次引用。我们只纳入了2013年(2013-2023年)以来发表的英语写作研究。最终,我们检索了5项研究,涉及235名参与者。我们分别使用Cochrane随机试验偏倚风险工具(RoB2)和非随机干预研究偏倚风险工具(ROBINS-I)来评估随机和非随机研究的偏倚风险。结果:结果表明,四种训练方案提高了参与者的功能能力高达46%。改善体重、BMI、超声心动图和重塑参数(左心房容积指数、室性早搏负荷、肺动脉收缩压)、运动试验结果(分钟通气量/二氧化碳生成、峰值负荷、心率储备、运动持续时间、心率峰值、收缩压峰值和血压对运动正常化的反应);这些研究报道了N端原脑钠肽(NT-pro BNP)的减少。无重大不良事件,包括持续的心动过速、植入式心律转复除颤器放电和心源性猝死。结论:有监督的运动训练对HCM患者是安全有益的。它可以提高运动能力,被认为是一种辅助治疗选择。
{"title":"Physical cardiac rehabilitation effects on cardio-metabolic outcomes in the patients with hypertrophic cardiomyopathy: a systematic review.","authors":"Fatemeh Chichagi, Kimiya Ghanbari-Mardasi, Niyousha Shirsalimi, Mahboobeh Sheikh, Diaa Hakim","doi":"10.62347/JOYM3506","DOIUrl":"10.62347/JOYM3506","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aimed to review existing evidence to evaluate the effects of physical cardiac rehabilitation on cardio-pulmonary outcomes in the patients with hypertrophic cardiomyopathy (HCM).</p><p><strong>Methods: </strong>We conducted a systematic search of the databases PubMed, Web of Science, Embase, Scopus, and Google Scholar. The initial search led to 1222 citations after removing duplicate results. We included only English-written studies published since 2013 (2013-2023). Ultimately, we retrieved five studies, involving 235 participants. We used the Cochrane Risk of Bias Tool for randomized trials (RoB2) and risk of bias in non-randomized studies of intervention (ROBINS-I) for evaluating the risk of bias in randomized and non-randomized studies, respectively.</p><p><strong>Results: </strong>Results showed that four training programs improved participants' functional capacity by up to 46%. Improvements in weight, BMI, echocardiography, and remodeling parameters (left atrium volume index, premature ventricular contraction burden, pulmonary artery systolic pressure), exercise test results (minute ventilation/carbon dioxide production, peak workload, heart rate reserve, exercise duration, peak heart rate, peak systolic pressure, and blood pressure response to exercise normalization), and a decrease in N- Terminal Pro-Brain Natriuretic Peptide (NT-pro BNP) were reported in these studies. No major adverse events, including sustained tachyarrhythmia, implantable cardioverter-defibrillator discharge, and sudden cardiac death were reported.</p><p><strong>Conclusion: </strong>Supervised exercise training is safe and helpful for patients diagnosed with HCM. It can improve exercise capacity and is considered an adjunctive therapeutic option.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"14 6","pages":"330-341"},"PeriodicalIF":1.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of cardiovascular disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1